Wada, Naoki, Takaaki Murakami, Muhammad Fauzi, Kentaro Sakaki, Shinobu Oshima, Yoshihito Shimada, Kanae Asai, et al. “Elevated Serum Growth Differentiation Factor 15 Levels As a Potential Biomarker of the Efficacy of Imeglimin in Individuals With Type 2 Diabetes Mellitus: An Exploratory Study”. Journal of Clinical Medicine Research 16, no. 10 (January 10, 2025): 503–508. Accessed April 2, 2025. https://jocmr.elmerjournals.com/jocmr/article/view/6031.